These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33404325)

  • 1. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control.
    Cobry EC; Kanapka LG; Cengiz E; Carria L; Ekhlaspour L; Buckingham BA; Hood KK; Hsu LJ; Messer LH; Schoelwer MJ; Emory E; Ruedy KJ; Beck RW; Wadwa RP; Gonder-Frederick L;
    Diabetes Technol Ther; 2021 Jun; 23(6):401-409. PubMed ID: 33404325
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial.
    Kudva YC; Laffel LM; Brown SA; Raghinaru D; Pinsker JE; Ekhlaspour L; Levy CJ; Messer LH; Kovatchev BP; Lum JW; Beck RW; Gonder-Frederick L;
    Diabetes Technol Ther; 2021 Oct; 23(10):673-683. PubMed ID: 34115959
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes.
    Kanapka LG; Wadwa RP; Breton MD; Ruedy KJ; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer MJ; Jost E; Carria L; Emory E; Hsu LJ; Weinzimer SA; DeBoer MD; Buckingham BA; Oliveri M; Kollman C; Dokken BB; Cherñavvsky D; Beck RW;
    Diabetes Care; 2021 Feb; 44(2):473-478. PubMed ID: 33355258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.
    Wheeler BJ; Collyns OJ; Meier RA; Betts ZL; Frampton C; Frewen CM; Galland B; Hewapathirana NM; Jones SD; Chan DSH; Roy A; Grosman B; Kurtz N; Shin J; Vigersky RA; de Bock MI
    Acta Diabetol; 2022 Jan; 59(1):31-37. PubMed ID: 34453208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial.
    O'Malley G; Messer LH; Levy CJ; Pinsker JE; Forlenza GP; Isganaitis E; Kudva YC; Ekhlaspour L; Raghinaru D; Lum J; Brown SA;
    Diabetes Technol Ther; 2021 Apr; 23(4):245-252. PubMed ID: 33155824
    [No Abstract]   [Full Text] [Related]  

  • 7. Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents.
    Bisio A; Brown SA; McFadden R; Pajewski M; Yu PL; DeBoer M; Schoelwer MJ; Bonner HG; Wakeman CA; Cherñavvsky DR; Gonder-Frederick L
    Pediatr Diabetes; 2021 May; 22(3):495-502. PubMed ID: 33289242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
    Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
    Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System.
    Schoelwer MJ; Kanapka LG; Wadwa RP; Breton MD; Ruedy KJ; Ekhlaspour L; Forlenza GP; Cobry EC; Messer LH; Cengiz E; Jost E; Carria L; Emory E; Hsu LJ; Weinzimer SA; Buckingham BA; Lal RA; Oliveri MC; Kollman CC; Dokken BB; Cherñavvsky DR; Beck RW; DeBoer MD;
    Diabetes Technol Ther; 2021 Jul; 23(7):475-481. PubMed ID: 33689454
    [No Abstract]   [Full Text] [Related]  

  • 10. Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial.
    Isganaitis E; Raghinaru D; Ambler-Osborn L; Pinsker JE; Buckingham BA; Wadwa RP; Ekhlaspour L; Kudva YC; Levy CJ; Forlenza GP; Beck RW; Kollman C; Lum JW; Brown SA; Laffel LM;
    Diabetes Technol Ther; 2021 May; 23(5):342-349. PubMed ID: 33216667
    [No Abstract]   [Full Text] [Related]  

  • 11. Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial.
    Kovatchev BP; Kollar L; Anderson SM; Barnett C; Breton MD; Carr K; Gildersleeve R; Oliveri MC; Wakeman CA; Brown SA
    Lancet Digit Health; 2020 Feb; 2(2):e64-e73. PubMed ID: 32864597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.
    Pinsker JE; Müller L; Constantin A; Leas S; Manning M; McElwee Malloy M; Singh H; Habif S
    Diabetes Technol Ther; 2021 Feb; 23(2):120-127. PubMed ID: 32846114
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents.
    Cobry EC; Hamburger E; Jaser SS
    Diabetes Technol Ther; 2020 Nov; 22(11):794-800. PubMed ID: 32212971
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review.
    Speight J; Choudhary P; Wilmot EG; Hendrieckx C; Forde H; Cheung WY; Crabtree T; Millar B; Traviss-Turner G; Hill A; Ajjan RA
    Diabet Med; 2023 Jan; 40(1):e14944. PubMed ID: 36004676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
    Fuchs J; Allen JM; Boughton CK; Wilinska ME; Thankamony A; de Beaufort C; Campbell F; Yong J; Froehlich-Reiterer E; Mader JK; Hofer SE; Kapellen TM; Rami-Merhar B; Tauschmann M; Hood K; Kimbell B; Lawton J; Roze S; Sibayan J; Cohen N; Hovorka R;
    BMJ Open; 2021 Feb; 11(2):e042790. PubMed ID: 33579766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    Diabet Med; 2023 Feb; 40(2):e15015. PubMed ID: 36424877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI).
    Petrovski G; Al Khalaf F; Campbell J; Day E; Almajaly D; Hussain K; Pasha M; Umer F; Hamdan M; Khalifa A
    BMC Endocr Disord; 2022 Mar; 22(1):80. PubMed ID: 35351095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a closed-loop control system and a virtual educational camp for children and adolescents with type 1 diabetes: A prospective, multicentre, real-life study.
    Cherubini V; Rabbone I; Berioli MG; Giorda S; Lo Presti D; Maltoni G; Mameli C; Marigliano M; Marino M; Minuto N; Mozzillo E; Piccinno E; Predieri B; Ripoli C; Schiaffini R; Rigamonti A; Salzano G; Tinti D; Toni S; Zanfardino A; Scaramuzza AE; Gesuita R; ; Tiberi V; Savastio S; Pigniatiello C; Trada M; Zucchini S; Redaelli FC; Maffeis C; Bassi M; Rosanio FM; Delvecchio M; Buzzi P; Ricciardi MR; Carducci C; Bonfanti R; Lombardo F; Piccini B; Iafusco D; Calandretti M; Daga FA
    Diabetes Obes Metab; 2021 Nov; 23(11):2484-2491. PubMed ID: 34227214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
    Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.